Suppr超能文献

南非接受抗逆转录病毒疗法的 HIV 阳性青少年队列中可检测到的病毒载量模式。

Patterns of detectable viral load in a cohort of HIV-positive adolescents on antiretroviral therapy in South Africa.

机构信息

Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa.

Groote Schuur Hospital, Cape Town, South Africa.

出版信息

J Int AIDS Soc. 2020 Mar;23(3):e25474. doi: 10.1002/jia2.25474.

Abstract

INTRODUCTION

Despite improved treatment and access to care, adolescent AIDS deaths are decreasing more slowly than in any other age group. There is lack of longitudinal data around adolescent adherence and the dynamics of viraemia over time. We aimed to describe patterns of detectable viral load (VL) in a cohort of adolescents attending an ARV clinic in Cape Town, South Africa.

METHODS

We conducted a retrospective cohort study of all patients on antiretroviral therapy aged 10 to 19 years. Participants were included if they underwent at least two VL measurements and remained in care at the Groote Schuur Hospital HIV Clinic for at least 24 months between 2002 and 2016. The primary outcome was two consecutive HIV VL >100 copies/mL, in line with the lower limit of detection of assays in use over the follow-up period.

RESULTS AND DISCUSSION

Of the 482 screened participants, 327 met inclusion criteria. Most participants had perinatally acquired HIV (n = 314; 96%), and 170 (52%) were males. Overall, there were 203 episodes of confirmed detectable VL involving 159 (49% (95% CI 43% to 54%)) participants during the follow-up period. Six participants had genotyped resistance to protease inhibitors. Four of these never suppressed, while two suppressed on salvage regimens. Total follow-up time was 1723 person years (PY), of which 880 (51%) were contributed by the 159 participants who experienced detectable VL. Overall time with detectable VL was 370 PY. This comprised 22% of total follow-up time, and 42% of the follow-up time contributed by those who experienced detectable VL. The rate of detectable VL was 11.8 (95% CI 10.3 to 13.5) episodes per 100 PY. The risk increased by 24% for each year of increasing age (Relative Risk 1.24 (95% CI 1.17 to 1.31); p < 0.0001). There was no sex difference with respect to duration (p = 0.4), prevalence (p = 0.46) and rate (p = 0.608) of detectable VL.

CONCLUSIONS

Clinicians need to be alert to the high prevalence of detectable VL during adolescence so as to pre-empt it and act swiftly once it is diagnosed. This study helps to highlight the risk of detectable VL that is associated with increase in age as well the high proportion of time that poorly adherent adolescents spend in this state.

摘要

简介

尽管治疗和获得护理的机会有所改善,但青少年艾滋病死亡人数的减少速度比任何其他年龄组都要慢。目前缺乏关于青少年坚持治疗和病毒载量随时间变化的纵向数据。我们旨在描述在南非开普敦的一个接受抗逆转录病毒治疗的青少年队列中可检测到的病毒载量 (VL) 的模式。

方法

我们对所有在 2002 年至 2016 年间接受过至少两次 VL 测量并在 Groote Schuur 医院 HIV 诊所至少接受 24 个月护理的年龄在 10 至 19 岁之间的接受抗逆转录病毒治疗的患者进行了回顾性队列研究。如果参与者在随访期间连续两次 HIV VL>100 拷贝/毫升(符合检测下限),则符合纳入标准。

结果与讨论

在筛选出的 482 名参与者中,有 327 名符合纳入标准。大多数参与者为围产期感染 HIV(n=314;96%),170 名(52%)为男性。总的来说,在随访期间,有 203 例确诊可检测到 VL 的病例,涉及 159 名(49%(95%CI 43%至 54%))参与者。6 名参与者的蛋白酶抑制剂基因型具有耐药性。其中 4 名从未抑制,而 2 名在挽救方案中抑制。总随访时间为 1723 人年(PY),其中 159 名经历可检测到 VL 的参与者的随访时间为 880 人年(51%)。可检测到 VL 的总时间为 370 PY。这占总随访时间的 22%,占经历可检测到 VL 的参与者随访时间的 42%。VL 可检测率为每 100 PY 11.8 例(95%CI 10.3 至 13.5)。年龄每增加 1 岁,VL 可检测的风险增加 24%(相对风险 1.24(95%CI 1.17 至 1.31);p<0.0001)。在 VL 可检测的持续时间(p=0.4)、患病率(p=0.46)和发生率(p=0.608)方面,性别之间无差异。

结论

临床医生需要警惕青少年时期 VL 可检测的高患病率,以便在发现时预先防范,并在确诊后迅速采取行动。本研究有助于突出与年龄增长相关的 VL 可检测风险,以及青少年坚持治疗不良的比例很高,且处于这种状态的时间很长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d18f/7076279/81e5ec1ac24b/JIA2-23-e25474-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验